Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated to proteinaceous toxin or fragment thereof
Patent
1980-10-06
1983-08-30
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated to proteinaceous toxin or fragment thereof
424180, 536 175, 536 21, A61K 31725, C08B 3710
Patent
active
044016620
ABSTRACT:
Oligosaccharides obtainable from heparin including heparinic constituents of molecular weights ranging from 2000 to 50,000. Said fractions have a Yin-Wessler titer and a USP titer in a ratio of at least 30. They consist of chains constituted by no more than 8 saccharidic moities. They possess a strong antithrombotic activity and are then useful as antithrombotic drugs.
REFERENCES:
patent: 3506642 (1970-04-01), Koh et al.
patent: 3985871 (1976-10-01), Butti et al.
patent: 4122250 (1978-10-01), Schmer
patent: 4175182 (1979-11-01), Schmer
patent: 4213962 (1980-07-01), Miura et al.
patent: 4281108 (1981-07-01), Fussi
Choay Jean
Lormeau Jean-Claude
Petitou Maurice
Brown Johnnie R.
Choay S.A.
LandOfFree
Oligosaccharides having anti-Xa activity and pharmaceutical comp does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligosaccharides having anti-Xa activity and pharmaceutical comp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligosaccharides having anti-Xa activity and pharmaceutical comp will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-905616